Evaluation of cellular immune responses in subjects chronically infected with HIV type 1
- PMID: 17263635
- DOI: 10.1089/aid.2006.0114
Evaluation of cellular immune responses in subjects chronically infected with HIV type 1
Abstract
The importance of host cellular immune responses, particularly CD8(+) cytotoxic T-lymphocyte (CTL) responses, in control of human immunodeficiency virus type 1 (HIV-1) infection has been demonstrated in many clinical studies. These studies, along with vaccination challenge studies in rhesus macaques, indicate the importance of cellular immune responses against HIV-1. Toward this end, we evaluated anti-HIV-1 cellular immune responses in a cohort of 54 subjects who were chronically infected with HIV-1. By validation of IFN-gamma ELISpot assay, we established a dual cut-off criterion for scoring a positive response. The magnitude and frequency of cellular immune responses were measured against HIV-1 antigens (Gag, Pol, Nef, Rev, and Tat), using synthetic peptides as antigens in ELISpot assay. Here we showed that HIV-1 Gag, Pol, and Nef were frequent targets of T cell responses in these subjects, whereas Tat and Rev were less frequently recognized. We further evaluated the possible association between host cellular immune responses and corresponding plasma viral loads in this cohort. By performing ranking correlation analysis, we demonstrated a positive correlation between host viral loads and ELISpot responses of HIV Gag and Pol in untreated subjects. For the subjects under antiviral regimens, however, we did not find any significant association. Our findings suggest that the high levels of ELISpot responses in chronically infected subjects were reflective of their persistent viral infection.
Similar articles
-
Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.AIDS Res Hum Retroviruses. 1995 Apr;11(4):481-9. doi: 10.1089/aid.1995.11.481. AIDS Res Hum Retroviruses. 1995. PMID: 7632463
-
Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.AIDS Res Hum Retroviruses. 1998 Jul 20;14(11):925-37. doi: 10.1089/aid.1998.14.925. AIDS Res Hum Retroviruses. 1998. PMID: 9686639
-
Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.J Infect Dis. 2005 Sep 1;192(5):749-59. doi: 10.1086/432547. Epub 2005 Jul 27. J Infect Dis. 2005. PMID: 16088824
-
Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma.J Virol. 2002 Mar;76(5):2298-305. doi: 10.1128/jvi.76.5.2298-2305.2002. J Virol. 2002. PMID: 11836408 Free PMC article.
-
Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.J Virol. 2007 Sep;81(17):9061-71. doi: 10.1128/JVI.00117-07. Epub 2007 Jun 20. J Virol. 2007. PMID: 17582003 Free PMC article.
Cited by
-
Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults.Malar J. 2011 Jun 20;10:168. doi: 10.1186/1475-2875-10-168. Malar J. 2011. PMID: 21689436 Free PMC article.
-
Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.Hum Gene Ther. 2008 Oct;19(10):979-90. doi: 10.1089/hum.2008.107. Hum Gene Ther. 2008. PMID: 18774912 Free PMC article. Clinical Trial.
-
Diverse cross-reactive potential and Vbeta gene usage of an epitope-specific cytotoxic T-lymphocyte population in monkeys immunized with diverse human immunodeficiency virus type 1 Env immunogens.J Virol. 2009 Oct;83(19):9803-12. doi: 10.1128/JVI.00776-09. Epub 2009 Jul 29. J Virol. 2009. PMID: 19640988 Free PMC article.
-
Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point.J Virol. 2009 Jan;83(1):470-8. doi: 10.1128/JVI.01678-08. Epub 2008 Oct 22. J Virol. 2009. PMID: 18945774 Free PMC article.
-
Retracing our STEP towards a successful CTL-based HIV-1 vaccine.Vaccine. 2008 Jun 13;26(25):3138-41. doi: 10.1016/j.vaccine.2008.02.027. Epub 2008 Feb 27. Vaccine. 2008. PMID: 18339458 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials